anti-viral drug

New Delhi: Leading pharmaceutical company Cipla has sought permission to launch Favipiravir, an anti-viral drug, in India to fight against COVID-19. Sources said the Council of Scientific…

New York: Remdesivir, the anti-viral drug that has shown promise in the fight against COVID-19, has been backed by more researchers. A recent study, published in the journal Cell Reports,…

Another anti-viral drug for the treatment of COVID-19 has been launched, this time by pharma major Cipla. To be sold in the market under the brand name of Cipremi, this one is a generic…